The Latest Breaking News from FDA

With the growing prevalence of chronic diseases, the adoption of advanced digital technologies, and new drug discoveries, the pharmaceutical industry is set to witness significant growth this year and beyond. Thus, it could be wise to invest in quality pharma stocks Ipsen (IPSEY), Supernus (SUPN), and Kamada (KMDA), which are…

With vaccines on the horizon, RSV could finally be preventable. But anti-vax misinfo could get in the way

The Opill contains a low dose of progestin at 0.075 milligrams per pill, and has to be taken at the same time every day.

The billionaire’s record has raised concerns over Neuralink’s ability to responsibly oversee the development of such an invasive device

Scientists debate the benefits of bivalent and monovalent shots

Brain implants developed by Elon Musk's company Neuralink have been approved for human testing. The safety of the devices previously came under scrutiny following reports of "botched surgeries" in animal test subjects.

Titanium dioxide, found in candy, meat substitutes and packaged cookies, has been linked to a range of serious health issues

Some compounding pharmacies are using unauthorized active ingredients to make copycat versions of Ozempic and Wegovy.

FDA has warned consumers against using ‘compounded’ versions of semaglutide, the key ingredient found in Ozempic and Wegovy